Introduction {#sec0005}
============

The coronavirus disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a global public health threat (X. [@bib0070]). The dynamics of SARS-CoV-2 transmission occurs from human-to-human through respiratory droplets ([@bib0040]), however, other routes of transmission have not been appropriately characterized.

The high-risk populations for COVID-19 include old-age individuals or people with severe comorbidity ([@bib0035]). Particularly, this novel coronavirus causes severe complications in pregnant women, which increases the risk of maternal morbidity ([@bib0055]). Also, proper documentation of the source and potential for mother-to-infant vertical transmission of SARS-CoV-2 is required to prevent cases of severe COVID-19 in newborn infants. We described the case of a mother with confirmed COVID-19 and her neonate that was positive for SARS-CoV-2 at the time of birth. Since the neonate had central cyanosis, dyspnea, and oxygen saturation of 87%, she was defined as a severe case of COVID-19.

The infant´s stool was positive for SARS-CoV-2 on the fifth day but not on the thirteenth day after birth, as well as the nasopharyngeal and oropharyngeal swabs recollected on the same day. Additionally, viral RNA was detected in the stool, and milk of the infected mother actively breastfeeding the neonate. This report provided evidence of the risk of intrauterine infection and breastfeeding as mechanisms for vertical transmission of SARS-CoV-2.

Case report {#sec0010}
===========

At 38 weeks of gestation, a twenty-one years old female (gravida 1, para 1) with fever (39.5 °C) for the last two days was admitted to the Gynecology and Obstetrics Hospital; the Mother-Child Institute from the State of Mexico, Mexico on May 21 st, 2020. The woman had contact with COVID-19 patients and developed symptoms such as coughing, odynophagia, headache, diarrhea, and rhinorrhea. Her sore throat, fever and symptoms started on May 19th, 2020. The chest radiograph showed patchy consolidation in the upper left lobe, and the patient was classified as a suspected case of COVID-19. The nasopharyngeal and oropharyngeal swabs taken on May 21 st, 2020 were positive for SARS-CoV-2 by Real-Time Reverse Transcriptase-Polymerase Chain Reaction (real-time RT-PCR).

In addition, the acute hypoxemic respiratory failure and atypical pneumonia were consistent with COVID-19. On day 1 at the hospital, she had painful and irregular contractions. Therefore, an emergency caesarian section was performed, and she delivered a female infant. The newborn weighed 3,075 g, the Apgar score was 8/9 and required only routine resuscitation. The infant´s body temperature was 36.5 °C, and her heart rate was 140 beats per minute, with a respiratory rate of 52 breaths per minute. The newborn was separated from her mother immediately after birth without skin-to-skin contact. Nasopharyngeal and oropharyngeal swabs samples were taken from the neonate during delivery and tested by real-time RT-PCR confirming the clinical diagnosis of SARS-CoV-2 infection with a low cycle threshold value (Orf1ab gene, 23), suggesting high viral load. Moreover, the neonate had newborn jaundice, tachypnea, hyponatremia, central cyanosis, dyspnea, and oxygen saturation of less than 92% (87%). Thus, this was defined as a severe case of COVID-19 (Yuanyuan [@bib0030]). The neonate was kept in the intensive care unit with oxygen therapy which was withdrawn when the oxygen saturation level was greater than 90%. The infant´s clinical laboratory results ([Table 1](#tbl0005){ref-type="table"} ) revealed that basophils, hemoglobin, hematocrit, total bilirubin, indirect bilirubin, and lactate dehydrogenase were above the normal range during the first six days after birth. In contrast, prothrombin time, platelets, and urea were below the normal range.Table 1Clinical Laboratory Results of Mother and Newborn Infant.Table 1Clinical Laboratory ResultsMotherNewborn InfantVariableReference rangeDay 2 after onset of symptoms (Hospital day 1)Reference rangeDay 1 after birthDay 3 after birthDay 6 after birthWhite blood cell count (x10^9^/L)4.5-1011.74.5-1716.4611.2312.16Lymphocyte count (x10^9^/L)1.1-3.21.83-84.65.38.5Lymphocyte ratio (%)21-4815.0921-65284769.9Monocyte ratio (%)\--2-12111210Basophil ratio (%)\--0-1006Eosinophil ratio (%)\--1-4250Neutrophil ratio (%)\--10-74593614.9Hemoglobin (g/dl)12-169.8512-1517.115.1818.39Hematocrit (%)37-4729.437-4050.2144.8255.17Prothrombin time (sec)11-1611.810-144.8\--Platelet count (per mm^3^)150,000-450,000348,000150,000-450,000218,000354,000126,000Globulin (g/dl)\--2-3.51.9\--Glucose (mg/dl)74-1067145-1265092-Cholesterol (mg/dl)≤200149\-\-\--Triglycerides (mg/dl)≤150342\-\-\--Total protein (g/dl)6.3-8.24.73.5-5.44.8\--Albumin (g/dl)3-54.32.5-3.92.9\--Total bilirubin (mg/dl)0.1-1.20.51.4-8.75.512.913.8Direct bilirubin (mg/dl)0-0.30.10-0.20.50.4-Indirect bilirubin (mg/dl)0.1-10.40.2-1.9512.4-Lactate dehydrogenase (U/liter)125-250221145-395646\--Alanine aminotransferase (U/liter)5-3415\-\-\--Aspartate aminotransferase (U/liter)5-341930-15045\--Creatinine (mg/dl)0.5-0.90.490.2-10.81-0.1Blood urea nitrogen (mg/dl)6-2064-1913-4Urea (mg/dl)16.6-48.512.814.9-4027.8-8.6Uric acid (mg/dl)2.4-5.75.21-75.5\--Magnesium (mg/dl)1.6-2.41.841.6-2.42.032.712.02Calcium (mg/dl)8.4-10-27.79-10.67.19.17.1Sodium (mmol/liter)136-145137136-145129131134Potassium (mmol/liter)3.5-5.13.13.7-7.24.95.25.4Chloride (mmol/liter)98-10711698-107109103100

On regard of the mother, she had severe respiratory depression and episodes of oxygen desaturation between 40-60% at the immediate postoperative period. Therefore, the patient received rapid sequence intubation and intensive care. After 24 h the extubation was performed when the mother showed adequate ventilation parameters. The mother was well and afebrile (37.3 °C) during the immediate post-extubation period with vital signs stable, respiratory rate of 22 breaths per minute, blood pressure of 107/87 mm Hg, and blood oxygen saturation \>90%. The patient was treated with anticoagulant therapy using Enoxaparin 40 mg/day via subcutaneous injection and antiviral therapy with Ivermectin 12 mg/single-dose oral administration. The mother´s clinical laboratory results ([Table 1](#tbl0005){ref-type="table"}) indicated that lymphocytes ratio, hemoglobin, hematocrit, total protein, urea, and calcium were below the normal range. At the same time, triglycerides were still above the normal range as on first-day hospital admission. Even though the lymphocyte ratio was below the normal range, the absolute lymphocyte count within the reference interval was found, as previously reported (L. [@bib0020]).

The newborn was feed with synthetic milk formula instead of human milk until she was confirmed with COVID-19, without any adverse effects. On day fourth after delivery (25 May), real-time RT-PCR analyses of the mother´s milk and stool samples were positive for SARS-CoV-2 RNA, similar result was obtained for the infant´s stool sample. On 3 June, after 13 days of delivery, the infant´s nasopharyngeal and oropharyngeal swabs and stool samples were negative for SARS-CoV-2 compared with the maternal samples which was remained positive. The mother and infant were discharged from the hospital when they had a resolution of respiratory symptoms and an uneventful postpartum and neonatal course.

Real-time RT-PCR of Clinical Specimens {#sec0015}
======================================

The written informed consent was obtained from the patient according to the Declaration of Helsinki 2013. Human milk, maternal stool, and infant´s stool or nasopharyngeal and oropharyngeal swabs were collected at or after cesarean delivery. The clinical sample collection, processing, and laboratory testing were based on WHO guidelines. Viral nucleic acid extraction from clinical specimens was performed using QIAamp Viral RNA Mini Kit (QIAGEN) according to the manufacturer´s instructions. Real-time RT-PCR was performed with the nucleic acid testing kit (Daan, Guangzhou, China) for SARS-CoV-2 detection according to the manufacturer´s instructions. The open reading frame 1 ab (ORF1ab) (forward primer 5´-ACC-TTC-TCT-TGC-CAC-TGT-AGC-3´, reverse primer 5´-AGT-ATC-AAC-CAT-ATC-CAA-CCA-TGT-C-3´, and probe FAM 5´-ACG-CAT-CAC-CCA-ACT-AGC-AGG-CAT-AT-BHQ1-3´) and nucleocapsid protein (N) (forward primer 5´-TTC-AAG-AAA-TTC-AAC-TCC-AG-3´, reverse primer 5´-AGC-AGC-AAA-GCA-AGA-GCA-GCA-TC-3´, and probe VIC 5´-TCC-TGC-TAG-AAT-GGC-TGG-CAA-TGG-CG-BHQ1-3´) were designed as the two target genes to the detection of SARS-CoV-2 in clinical samples. The thermal cycling was performed under the following conditions: incubation at 50 °C for 15 min and 95 °C for 15 min, 45 cycles of denaturation at 94 °C for 15 s, and extension and collection of fluorescence signal at 55 °C for 45 s. A cycle threshold value (Ct-value) ≤40 was defined as a positive result, whereas a Ct-value \>40 was considered a negative test.

Discussion {#sec0020}
==========

SARS-CoV-2 is responsible for the epidemic of the COVID-19 in worldwide ([@bib0040]). Previous reports suggest the intrauterine vertical transmission potential of SARS-CoV-2 and its implications on newborn infants (H. [@bib0010]; S. [@bib0065], [@bib0080]). Nevertheless, there is not enough evidence about how mother-to-infant vertical transmission occurs. Here, we reported the first case of SARS-CoV-2 infection in a neonate born to a woman with COVID-19 in Mexico. SARS-CoV-2 infection in the newborn infant was described as a severe case of COVID-19 because she had central cyanosis, dyspnea, and oxygen saturation of 87% (Yuanyuan [@bib0030]). Moreover, the newborn had thrombocytopenia accompanied by high lactate dehydrogenase levels, which suggested abnormal liver function (Y. [@bib0015], [@bib0080]). Lymphopenia (lymphocyte count of less than 1.5 × 10^9^/L) is an indicator of the severity in COVID-19 patients ([@bib0075]), however, it was not observed in the mother and newborn like a previous study (L. [@bib0020]). Even though the mother was treated with Ivermectin, we do not recommend its use since there are no clinical trials suggesting its efficacy against SARS-CoV-2 infection.

The infant was born by emergency caesarian without the premature rupture of the membrane or placental abruption, and with airborne transmission precautions. Also, we did not observe that the newborn swallowed amniotic fluid. Thus, we rule out that these are the causes of SARS-CoV-2 detection in the newborn. Her nasopharyngeal and oropharyngeal swabs samples taken immediately after birth were positive for SARS-CoV-2, suggesting intrauterine vertical transmission. Nevertheless, no umbilical cord or placenta tests were performed, so whether the SARS-CoV-2 infection was acquired by intrauterine transmission cannot be confirmed. A recent report has demonstrated the transplacental transmission of SARS-CoV-2 with clinical manifestation in the neonate ([@bib0060]), as in this case, which confirms that the mother-to-infant transmission is possible. Therefore, SARS-CoV-2 infection could be considered as a TORCH (Toxoplasmosis, Other (syphilis, varicella-zoster and parvovirus B19), Rubella, Cytomegalovirus, and Herpes simplex virus) infection ([@bib0050]). The fact that this case is an intrauterine vertical transmission or not remains controversial, but this is not ruled out. Also, we rule out SARS-CoV-2 infection in the newborn infant as nosocomial. Since the risk of infection was reduced according to Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable SARS ([@bib0045]).

On the other hand, the shedding of SARS-CoV-2 RNA in stool from both patients and breast milk was detected. Thus, human breast milk could be involved in SARS-CoV-2 transmission from mother to newborn infant during breastfeeding but not in this case. However, it is not yet known how SARS-CoV-2 shedding occurs in breast tissue, and whether this viral RNA represents infectious viral particles. We ruled out that the milk had been contaminated because the self-expression of human milk was performed with hand hygiene and after breast decontamination, and it was expressed directly into a sterile specimen container. Although SARS-CoV-2 RNA was not detected in breast milk thirteen days after delivery, it may contain a low viral load or even elevated IgM and IgA antibodies against virus, as has been reported (D. [@bib0005]; Yunzhu [@bib0025]). Since human breast milk is essential for provide immunity to the infant, the monitoring of the human milk banks is required to prevent the risk of infection through breastfeeding. We recommend that whether SARS-CoV-2 RNA is detected in breast milk, the breastfeeding could be suspended but instead pump the milk to avoid mastitis. Nevertheless, the benefits of human milk could greatly outweigh the risk of vertical transmission of COVID-19 since it contains IgM and IgA antibodies to SARS-CoV-2 (Yunzhu [@bib0025]), suggesting that breastfeeding might have a protective role in neonates. Further studies will determine whether breastfeeding is appropriate during maternal COVID-19 infection. In summary, this report provided evidence on the risk of SARS-CoV-2 infection during pregnancy and breastfeeding.
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